SINTX Technologies Divests Subsidiary to Strengthen Focus on Medical Devices
February 20, 2025 - 20:13
Salt Lake City, UT, Feb. 20, 2025 – SINTX Technologies, Inc., a prominent player in advanced ceramics for medical applications, has announced the strategic sale of its wholly-owned subsidiary, Technology Assessment and Transfer (TA&T), to Tethon Corporation, also known as Tethon 3D. This pivotal transaction is designed to enhance SINTX’s financial flexibility and sharpen its focus on the burgeoning medical device market.
By divesting TA&T, SINTX aims to streamline its operations and concentrate resources on developing innovative healthcare solutions. The sale is expected to provide the company with additional capital, which will be directed towards advancing its core competencies in medical technologies.
SINTX's leadership believes that this move will not only bolster its competitive edge but also facilitate growth in a sector that is increasingly reliant on cutting-edge materials and manufacturing processes. The company remains committed to its mission of delivering high-quality medical products that improve patient outcomes.
MORE NEWS
June 7, 2025 - 20:23
Yageo Corp. to Retain Shibaura's AI Technology in Japan Following AcquisitionTaiwan`s Yageo Corp. has announced its intention to maintain the advanced artificial intelligence technology of Shibaura Electronics Co. in Japan, contingent upon a successful acquisition of the...
June 7, 2025 - 00:28
Pankaj K. Jha Awarded NSF Grant for Quantum Technology ResearchPankaj K. Jha, a prominent professor in the field of quantum technology, has recently been awarded a significant grant from the National Science Foundation (NSF) to further his research on...
June 6, 2025 - 01:39
Utilizing Smart Manufacturing Technology for the Next Generation of CNC MachinistsIn an era marked by rapid technological advancements, the manufacturing industry faces a pressing challenge: bridging the skills gap in the workforce. As smart manufacturing technologies continue...
June 5, 2025 - 09:18
FDA Greenlights Innovative AI Tool for Enhanced Breast Cancer DetectionA groundbreaking development in breast cancer detection has received approval from the FDA. This new AI technology, created by a pioneering tech company, marks the first instance of an FDA-approved...